Other mechanisms include amplification of the MET gene20,21, PIK3CA mutation21,22, BRAF mutation23, epithelial-to-mesenchymal transition (EMT)21 and small cell lung cancer (SCLC) transformation20,21. This evidence concerns the gene BRAF and small cell lung carcinoma.